Age Labs
Age Labs is a Norwegian life science company founded in 2017, specializing in the discovery, development, and commercialization of diagnostic tests for the early detection of age-related diseases. Leveraging advanced machine learning on epigenetic datasets, the company identifies biomarkers for early disease detection and assesses disease risk. Their pipeline includes a test for rheumatoid arthritis, a biological age predictor, and a COVID-19 severity predictor. Age Labs offers services to the pharmaceutical, nutraceutical, and health & wellness sectors, including custom biomarker development and biological age measurements. Their proprietary platform, EPIPHANY, combined with access to biosamples and longitudinal clinical data, allows for extensive epigenetic reports that correlate disease mechanisms and drug effects. The company collaborates with leading global institutions and has received funding from Innovation Norway and the Research Council of Norway.
Age Labs
Age Labs is a Norwegian life science company founded in 2017, specializing in the discovery, development, and commercialization of diagnostic tests for the early detection of age-related diseases. Leveraging advanced machine learning on epigenetic datasets, the company identifies biomarkers for early disease detection and assesses disease risk. Their pipeline includes a test for rheumatoid arthritis, a biological age predictor, and a COVID-19 severity predictor. Age Labs offers services to the pharmaceutical, nutraceutical, and health & wellness sectors, including custom biomarker development and biological age measurements. Their proprietary platform, EPIPHANY, combined with access to biosamples and longitudinal clinical data, allows for extensive epigenetic reports that correlate disease mechanisms and drug effects. The company collaborates with leading global institutions and has received funding from Innovation Norway and the Research Council of Norway.